- Home
- DARE vs GDTC Comparison
DARE vs GDTC Comparison
Compare DARE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- GDTC
- Stock Information
- Founded
- DARE 2015
- GDTC 2018
- Country
- DARE United States
- GDTC Singapore
- Employees
- DARE N/A
- GDTC N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- DARE Health Care
- GDTC Health Care
- Exchange
- DARE Nasdaq
- GDTC Nasdaq
- Market Cap
- DARE 26.3M
- GDTC 28.0M
- IPO Year
- DARE N/A
- GDTC 2023
- Fundamental
- Price
- DARE $2.52
- GDTC $2.21
- Analyst Decision
- DARE Strong Buy
- GDTC Buy
- Analyst Count
- DARE 3
- GDTC 1
- Target Price
- DARE $12.50
- GDTC $5.00
- AVG Volume (30 Days)
- DARE 443.5K
- GDTC 6.5K
- Earning Date
- DARE 08-11-2025
- GDTC 01-01-0001
- Dividend Yield
- DARE N/A
- GDTC N/A
- EPS Growth
- DARE N/A
- GDTC N/A
- EPS
- DARE N/A
- GDTC N/A
- Revenue
- DARE $25,909.00
- GDTC $368,838.00
- Revenue This Year
- DARE $99,756.91
- GDTC $5.37
- Revenue Next Year
- DARE $119.77
- GDTC N/A
- P/E Ratio
- DARE N/A
- GDTC N/A
- Revenue Growth
- DARE N/A
- GDTC N/A
- 52 Week Low
- DARE $2.11
- GDTC $1.20
- 52 Week High
- DARE $4.60
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- DARE 41.75
- GDTC 49.36
- Support Level
- DARE $2.37
- GDTC $2.09
- Resistance Level
- DARE $2.54
- GDTC $2.35
- Average True Range (ATR)
- DARE 0.14
- GDTC 0.10
- MACD
- DARE -0.00
- GDTC 0.00
- Stochastic Oscillator
- DARE 59.56
- GDTC 50.00
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.